i like your analogy of a marathon; how true. ICNB does and

New Post Public Reply Private Reply Replies (0) Message Board
joey68 Trappist-1 #2129
224
i like your analogy of a marathon; how true. ICNB does and will have ups and downs. many people will fall away and the stronger investors will keep going. I definetely believe a gap up is coming followed by several or more hollow heikin candles. this will be followed by a 'crash' as the price resets for the next leg up. more runners will fall away, and stronger investors will join in. im expecting every 10q this year to show increasing revenues. again thanks for that analogy. i never thought of it like that. i may incorporate that into a new investment strategy of mine. maybe ill call it 'The Marathon Strategy'

My other two strategies for those interested:

My Investment Strategies

'Rule of Numbers' method
http://investorshangout.com/post/view?id=4077000

'Unknown Main Investment' method
http://investorshangout.com/post/view?id=4295303

i have something special for the next chart. im expecting a lot of WHAT THE HECK IS THAT YOU CRAZY PERSON??

.. but we're going to be using the heikin ashi chart for a while as well.

Iconic Brands, Inc. (ICNB) Stock Research Links

ICNB Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Attilio's Longevity Push: Science with a Personal Touch

Updated Category News Views 64

Reimagining Longevity: Beyond Just Adding Years Guess what? Living longer isn't just about reaching the milestone of blowing out 100 birthday candles. That's the message Attilio drilled home during their recent Longevity Event. And let me tell you, it was quite a doozy—from what went down at Stanford to a deep dive at the Buck Institute, it was an eye-opening affair....

Continue Reading
FCS Awareness Day Aims to Illuminate a Hidden Struggle

Updated Category News Views 109

The Underreported Battle of FCS Patients There's something to be said about bringing the invisible fights to the forefront—putting the unseen struggles of real people on public display. This Friday, Nov. 6, 2026, the Foundation for Triglyceride Disorders is doing just that with FCS Awareness Day. Their mission: spark conversations and shine a light on Familial...

Continue Reading
Ensign Group Lawsuit: A Wake-Up Call for Investors

Updated Category News Views 71

The Lowdown on Ensign's Recent Troubles Alright, folks, here's the scoop that might have you reaching for the Maalox. If you've put your chips on The Ensign Group, Inc. (NASDAQ: ENSG), you might want to keep your eyes peeled. Schall, Brown & Schwartz LLP—or SBS, as the pros call 'em—is ringing the alarm bells with a securities fraud suit that's got the potential to...

Continue Reading
Provider Services M&A Spark Interest Amid Market Changes

Updated Category News Views 61

A Gritty Look at the Provider Services Market Well, here's the deal: provider services mergers and acquisitions (M&A) are stirring back to life after dragging their feet through 2025. It's not a full-blown sprint yet, but we've got subtle signals of a market warming up to the idea of change and growth. Brown Gibbons Lang & Company (BGL) has the lowdown in their freshly...

Continue Reading
Admetec Shines Bright with New High-Magnification Headlights

Updated Category News Views 127

Admetec's Leap into Advanced Optical Solutions In the world of optical magnification, getting the right balance of visibility and comfort hasn't always been a straightforward journey. Now, Admetec, coming out of Haifa, Israel, is throwing a game-changer into the mix with their announcement of the Butterfly EVO+ and Orchid+ series. These ain't just any old headlights;...

Continue Reading
Tamarack Resort Hits West's Top 25 Ski Destinations

Updated Category News Views 35

Tamarack: Idaho's Hidden Gem Not every day you see an underdog snagging the spotlight, but Tamarack Resort in Idaho managed just that, muscling its way into SKI Magazine’s coveted list of the West’s top 25 ski resorts for 2027. For a spot that's often overshadowed by the glitzy, more popular names in skiing, this recognition is like a ticket to the big leagues. But...

Continue Reading
Multi-Society Panel Boosts Vaccine Guidance Clarity

Updated Category News Views 66

Vaccination Confusion: Could Clarity Finally Be Here? Here's the scoop, folks. In the swirling mess of immunization advice, a coalition of top medical societies has thrown a lifeline to clinicians. If you're drowning in conflicting vaccine guidance, this panel's unified stance might just be your life raft. The Coalition Forces of Immunization We have the Vaccine Guidance...

Continue Reading
Sabre's Q3 Earnings: What Investors Need to Know

Updated Category News Views 94

Unpacking Sabre's Latest Financial Reveal Sabre Corporation, that familiar name in travel tech, let the third quarter numbers out of the bag. Published fresh off the wire on November 5th, this round of figures covers the books up until September 30, 2026. If you're wired into NASDAQ:SABR, this is your bread and butter for the quarter. The figures, straight from Sabre's...

Continue Reading
3D Systems Faces Scrutiny Over Earnings Report

Updated Category News Views 65

3D Systems' Earnings Leave Investors on Edge Like a hot potato, 3D Systems’ latest earnings report has investors feeling jittery. And with good reason–their third-quarter numbers are a mixed bag as they somehow squeezed out a positive $3.1 million in adjusted EBITDA and yet posted a yawning $33.5 million GAAP net loss. No wonder heads are spinning over at SueWallSt,...

Continue Reading
Vaudit Welcomes Industry Veteran David Coleman

Updated Category News Views 81

David Coleman: Vaudit's New Ad Chief David Coleman stepping into Vaudit's spotlight as President of Advertising Industry is a twist worth watching. Vaudit, for those not up to speed, is an AI-driven powerhouse that keeps vendors in line with what they're charging. And let me tell you, Coleman's kind of heavy-hitter leadership doesn't come cheap, nor does it play nice with...

Continue Reading

Top 5 Most Recently Viewed Articles

Envision Consulting Paving the Way for Nonprofit Success

Updated Category News Views 224

Envision Consulting Grows as a Leader in Nonprofit Mergers With its fifth transaction in just one year, Envision Consulting is setting a remarkable example in the nonprofit sector. This organization, which has developed a significant national presence over more than fourteen years, is becoming a recognized leader in the field of nonprofit mergers and acquisitions. In the...

Continue Reading
Breakthrough Diagnostic Tools by GEARWRENCH for Mechanics

Updated Category News Views 228

Introducing GEARWRENCH's Innovative Diagnostic Tools GEARWRENCH is transforming the automotive service industry with the introduction of three state-of-the-art diagnostic tools tailored specifically for mechanics. These innovative tools are designed to simplify the car repair process, allowing technicians to diagnose and address issues more efficiently. Advantages of...

Continue Reading
Timothy Plan to Merge ETFs: Key Details and Insights Revealed

Updated Category News Views 128

Understanding the Recent Merger of Timothy Plan ETFs In a significant move, Timothy Partners, Ltd. has announced the merger of its Timothy Plan Large Mid/Cap Core Enhanced ETF (TPLE) into the Timothy Plan Large Mid/Cap Core ETF (TPLC). The merger, endorsed by the Board of Trustees, signifies a strategic response to evolving market demands and aims to streamline their...

Continue Reading
Greece's Luxury Real Estate Market Gains Favor Among UHNWIs

Updated Category News Views 350

Emerging Trends in Greece's Luxury Real Estate Market A recent study surveying over 250 ultra-high-net-worth individuals (UHNWIs) from 30 countries has unveiled significant insights into Greece's luxury real estate market. The survey showed that a remarkable 63% of respondents intend to purchase property, although half of them are also considering alternative...

Continue Reading
Sanara MedTech Inc. Partners with Biomimetic Innovations for OsStic™

Updated Category News Views 191

Sanara MedTech Inc. Partners with Biomimetic Innovations for OsStic™ Sanara MedTech Inc. (Nasdaq: SMTI), a forward-thinking medical technology company, has recently joined forces with Biomimetic Innovations Ltd (BMI) to provide an exciting update regarding the innovative product, OsStic™. This strategic partnership is paving the way for OsStic™'s introduction to the...

Continue Reading